445 related articles for article (PubMed ID: 26430399)
21. Liver transplantation for hepatocellular carcinoma: Korean experience.
Lee S; Ahn C; Ha T; Moon D; Choi K; Song G; Chung D; Park G; Yu Y; Choi N; Kim K; Kim K; Hwang S
J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):539-47. PubMed ID: 19727542
[TBL] [Abstract][Full Text] [Related]
22. Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma.
Akamatsu N; Sugawara Y; Kokudo N
World J Hepatol; 2014 Sep; 6(9):626-31. PubMed ID: 25276278
[TBL] [Abstract][Full Text] [Related]
23. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
24. Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies.
Lei J; Yan L
J Gastrointest Surg; 2012 Nov; 16(11):2120-5. PubMed ID: 22948843
[TBL] [Abstract][Full Text] [Related]
25. Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?
Saidi RF; Li Y; Shah SA; Jabbour N
Int J Organ Transplant Med; 2013; 4(4):137-43. PubMed ID: 25013666
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.
Lei J; Yan L; Wang W
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1340-6. PubMed ID: 23652915
[TBL] [Abstract][Full Text] [Related]
27. Living
Ogawa K; Takada Y
Transl Gastroenterol Hepatol; 2016; 1():35. PubMed ID: 28138602
[TBL] [Abstract][Full Text] [Related]
28. Does living donation have advantages over deceased donation in liver transplantation?
Kaido T; Uemoto S
J Gastroenterol Hepatol; 2010 Oct; 25(10):1598-603. PubMed ID: 20880167
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
Fisher RA; Kulik LM; Freise CE; Lok AS; Shearon TH; Brown RS; Ghobrial RM; Fair JH; Olthoff KM; Kam I; Berg CL;
Am J Transplant; 2007 Jun; 7(6):1601-8. PubMed ID: 17511683
[TBL] [Abstract][Full Text] [Related]
30. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results.
Di Sandro S; Giacomoni A; Slim A; Lauterio A; Mangoni I; Mihaylov P; Pirotta V; Aseni P; De Carlis L
Hepatogastroenterology; 2012; 59(114):505-10. PubMed ID: 22353516
[TBL] [Abstract][Full Text] [Related]
31. Predictors of Outcome of Living Donor Liver Transplantation for Hepatocellular Carcinoma.
Zakaria HM; Sallam AN; Ayoub II; Saleh SM; Maher D; Omar H; Abou-Shady M; Salama IA; Soliman EA; Abou El-Ella K; Ibrahim TM; Hammad EM
Indian J Surg; 2017 Aug; 79(4):299-307. PubMed ID: 28827903
[TBL] [Abstract][Full Text] [Related]
32. Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria.
Bhangui P; Saigal S; Gautam D; Piplani T; Choudhary N; Chaudhary R; Yadav S; Thiagarajan S; Rastogi A; Saraf N; Nundy S; Soin AS
Liver Transpl; 2021 Feb; 27(2):209-221. PubMed ID: 33253492
[TBL] [Abstract][Full Text] [Related]
33. Can living donor liver transplantation provide similar outcomes to deceased-donor liver transplantation for hepatocellular carcinoma? A systematic review and meta-analysis.
Elkomos BE; Abdo M; Mamdouh R; Abdelaal A
Hepatol Int; 2023 Feb; 17(1):18-37. PubMed ID: 36564609
[TBL] [Abstract][Full Text] [Related]
34. Balanced approach can help initial outcomes: analysis of initial 50 cases of a new liver transplantation program in East Asia.
Kim DS; Yu YD; Jung SW; Yang KS; Seo YS; Um SH; Suh SO
Ann Surg Treat Res; 2014 Jul; 87(1):22-7. PubMed ID: 25025023
[TBL] [Abstract][Full Text] [Related]
35. Living donor liver transplantation or hepatic resection combined with intraoperative radiofrequency ablation for Child-Pugh A hepatocellular carcinoma patient with Multifocal Tumours Meeting the University of California San Francisco (UCSF) criteria.
Xu X; Pu X; Jiang L; Huang Y; Yan L; Yang J; Wen T; Li B; Wu H; Wang W
J Cancer Res Clin Oncol; 2021 Feb; 147(2):607-618. PubMed ID: 32852635
[TBL] [Abstract][Full Text] [Related]
36. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.
Yankol Y; Bugeaud E; Zens T; Rizzari M; Mecit N; Leverson GE; Foley D; Mezrich JD; Kanmaz T; Andaçoğlu OM; D'Alessandro AM; Acarlı KS; Kalayoğlu M; Fernandez LA
Turk J Med Sci; 2021 Apr; 51(2):610-622. PubMed ID: 33037873
[TBL] [Abstract][Full Text] [Related]
37. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
38. Perioperative bacterial infections in deceased donor and living donor liver transplant recipients.
Varghese J; Gomathy N; Rajashekhar P; Venugopal K; Olithselvan A; Vivekanandan S; Naresh S; Sujatha C; Vijaya S; Jayanthi V; Rela M
J Clin Exp Hepatol; 2012 Mar; 2(1):35-41. PubMed ID: 25755404
[TBL] [Abstract][Full Text] [Related]
39. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
Vagefi PA; Ascher NL; Freise CE; Dodge JL; Roberts JP
Liver Transpl; 2012 Feb; 18(2):160-5. PubMed ID: 22006378
[TBL] [Abstract][Full Text] [Related]
40. Living donor liver transplantation for hepatocellular carcinoma.
Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
